Arameh is a product liability litigator who represents companies in a variety of industries including cosmetic, personal care products, medical device, pharmaceutical, retail, and electronics. She counsels manufacturers on issues arising throughout a product’s life cycle, including product labeling and marketing, risk assessment and prevention strategies, as well as corrective actions and recalls. In addition, Arameh represents companies in high-profile litigation and has extensive experience managing and coordinating complex class action and multidistrict litigation.
Arameh’s clients regard her as strategic and creative; they trust her commonsense approach to problem-solving and appreciate her ability to resolve disputes efficiently. Arameh is also deeply protective of her clients’ brand and business interests and leverages her knowledge of the legal and industry landscapes to help clients succeed.
She has been an integral part of numerous trial teams defending pharmaceutical and medical device manufacturers in mass tort litigation throughout the country. She also has significant experience effectively streamlining and coordinating mass tort litigation on a national, regional, and statewide level. This includes cultivating creative and compelling defense trial themes; training national trial teams; leading teams of local attorneys in consistent and aggressive national defense strategies; analyzing comprehensive case-specific data to facilitate global assessment; implementing document management protocols and litigation holds; identifying, developing, and presenting defense experts; and preparing company witnesses for testimony. Her unique ability to connect with witnesses and translate complex issues into persuasive, concise narratives makes her indispensable in bet-the-company litigation.
Education
- Pepperdine University (JD)
- McGill University (BA, Honors Political Science)
Experience
- Currently representing leading international medical device manufacturer in product liability and other general litigation throughout California and other jurisdictions relating to products ranging from EMS supplies, surgical instruments and power tools, to orthopedic implants and bone morphogenetic proteins.
- Provide ongoing counseling to medical device company with responsibility for handling, supervising, managing and/or directing the defense of their significant products liability matters and providing general advice regarding risk management, CAPA, recalls, pre-litigation strategy, litigation prevention and regulatory issues relating to their various divisions and product lines. Also supervised local counsel throughout the country and participated in trials in multiple venues.
- Serving as member of national coordinating and lead trial counsel team for a manufacturer of implantable orthopedic devices used in total hip arthroplasty alleged to cause various injuries in users stemming from metal debris and ions released in vivo.
- Served as member of national coordinating and lead trial counsel team for a national Fortune 500 life sciences company in two separate mass tort litigations involving different product lines.
- Part of trial team defending prominent orthopedic surgeon/researcher in mass product liability litigation for allegations relating solely to his participation in the design process, involving a large multi-disciplinary design team.
- Defending a supplier of sophisticated ventilation and air handling systems in a fatality case at a major Los Angeles Hospital. Multiple claims by the decedent heirs and several cross-complaints for equitable indemnity and apportionment of fault have been asserted in connection with the death of a hospital employee killed while servicing the relevant equipment.
- Served as key member of the California trial teams for large pharmaceutical client in massive products liability litigation involving company’s voluntary withdrawal of blockbuster nonsteroidal anti-inflammatory drug alleged to have caused heart attack, strokes and other injuries in thousands of users from the market. Played an integral role in the day-to-day coordination and management of thousands of lawsuits filed against the pharmaceutical company.
- Provided pre-marketing advice and counsel to world-leading medical device company regarding new technology for cardiac implants. Conducted extensive risk assessment for products contemplated for launch and provided recommendations for changes to product literature, launch materials, training of product representatives aimed at reducing products liability risk and exposure.
Recognition & Awards
- Recognized by Los Angeles Business Journal as one of the Most Influential Women Attorneys/Top Women Attorneys in Los Angeles (2018-2021)
- Included on the Southern California Super Lawyer: Rising Star – Personal Injury – Products: Defense list (2009 – 2020)
- Included on the Southern California Super Lawyer: Top Women Attorneys Rising Star – Personal Injury – Products: Defense list (2019)
- Graduate, International Association of Defense Counsel (IADC) Trial Academy, Stanford Law School
Involvement
- Subcommittee Chair, ABA Section of Litigation, Mass Torts Committee, Pharmaceutical and Medical Device
- Member, International Association of Defense Counsel (IADC)
Languages
- Farsi (Persian)
Recent Insights
Viewpoints
News & Press
Managing Member of Mintz’s Los Angeles Office Joshua Briones, Member Arameh Zargham O'Boyle, and Associate Matthew Novian co-authored an article published by Security magazine examining the U.S. Supreme Court’s recent ruling in TransUnion LLC v. Ramirez and its potentially significant implications for data breach and privacy class actions.
Events
Arameh O'Boyle will be participating in the Women in Legal & Corporate Leadership Summit [Virtual]: Los Angeles as a panelist for the panel "Parenthood & Career: Mastering the Balancing Act." The discussion will explore the challenges of a working mother and steps women can take to change the workplace culture to reduce stress and enhance productivity.
Viewpoints
California Becomes First State to Ban 24 Ingredients from Cosmetics and Personal Care Products
October 5, 2020 | Blog | By Arameh Zargham O'Boyle
California is the first state in the nation to ban certain ingredients – including formaldehyde, parabens, phthalates, per- and polyfluoralkyl substances (PFAS) and mercury – from cosmetics and personal care products. The Toxic-Free Cosmetics Act, signed into law by Governor Gavin Newsom on September 30, 2020, is aimed at chemicals often linked to cancer, reproductive harm, birth defects and endocrine disruption.
Read more
News & Press
Supreme Court Decision May Have Significant Implications for Data Breach and Privacy Class Actions
July 2, 2021
Managing Member of Mintz’s Los Angeles Office Joshua Briones, Member Arameh Zargham O'Boyle, and Associate Matthew Novian co-authored an article published by Security magazine examining the U.S. Supreme Court’s recent ruling in TransUnion LLC v. Ramirez and its potentially significant implications for data breach and privacy class actions.
Mintz Member Arameh O’Boyle and Associate Crystal Lopez co-authored an article published by Natural Products Insider examining proposed regulation and litigation risks associated with labeling cosmetics products as “natural.”
Legal Uncertainty Surrounding the Term ‘Natural’
July 13, 2020
Mintz Member Arameh O’Boyle and Associate Crystal Lopez co-authored an article published by Beauty Packaging Magazine that addressed how manufacturers, suppliers, distributors, and retailers can minimize litigation risks associated with labeling products as “natural.”
The Daily Journal covered Mintz’s second annual “Lawyer for a Day” event held on March 5 in the firm’s Los Angeles office. During the event, Mintz hosted approximately 30 middle school students from New Los Angeles Charter School, a Title One school, for conversations with firm attorneys and external in-house counsel panelists to learn more about the legal profession and what it’s like to be a lawyer.
"Newly Acquired Information” and Federal Preemption Defenses in Pharmaceutical Products Liability Cases
June 28, 2018
This column discusses preemption defenses employed in pharmaceutical products liability cases – chief among them is the Food and Drug Administration (FDA)’s Changes Being Effected (CBE) regulations which allow brand manufacturers to modify a product label without prior FDA approval. Mintz Litigation Member Arameh O’Boyle and Associate Clancy Galgay authored the piece.
Cosmetic Companies Must Plan For New Regulation
December 14, 2017
Arameh O’Boyle, a Member and Nada Shamonki, Of Counsel in the Mintz Los Angeles office, and Joanne Hawana, Of Counsel in the firm’s Washington, DC office collaborated on an article published in Law360 on regulatory changes to the cosmetics and personal care products industries.
Mintz Expands Los Angeles Office and Litigation Practice with Arrival of Products Liability Group
June 22, 2017
Mintz is expanding the firm’s Los Angeles office with the addition of a team of litigators led by Ralph A. Campillo and Arameh Zargham O’Boyle, joining as Members in the firm’s Litigation Practice. Associates Christopher Norton and Nicholas Weiss join them.
Events
Panelist
Nov
12
2020
The Women in Legal & Corporate Leadership Summit [Virtual]: Los Angeles
Los Angeles (VIrtual)
Panelist
Moderator
Moderator
Moderator
Apr
26
2018